Bachrodt Amy

SVP, FinanceMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$230K
Net Open-Market Flow
-$230K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Sell(S)736$46.63$34K13K
Feb 2, 2026Sell(S)4K$46.03$187K14K
Feb 2, 2026Option exercise(M)156$10.42$2K18K
Feb 2, 2026Option exercise(M)5K$10.42$50K18K
Feb 2, 2026Sell(S)200$44.15$9K18K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2026Option exercise(M)5K$03K
Feb 2, 2026Option exercise(M)156$041K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002050422-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly: